AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan
· Delayed Price · Currency is TWD 55.90
-0.60 (-1.06%)
Mar 9, 2026, 1:23 PM CST
AnnJi Pharmaceutical Company Description
AnnJi Pharmaceutical Co., Ltd. develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders.
It develops therapeutics, such as AJ201 for the treatment of spinal and bulbar muscular atrophy disease; AJ302, a histone deacetylase 6 inhibitor for the prevention and treatment of chemotherapy-induced peripheral neuropathy; and AJ303, an anti-fibrotic and anti-inflammatory compound for the treatment of idiopathic pulmonary fibrosis diseases.
AnnJi Pharmaceutical Co., Ltd. was founded in 2014 and is based in Taipei, Taiwan.
AnnJi Pharmaceutical Co., Ltd.
| Country | Taiwan |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Wenying Huang |
Contact Details
Address: 16F.-6, No. 508, Sec. 7 Taipei, 115011 Taiwan | |
| Phone | 886 2 2365 5677 |
| Website | ajpharm.com |
Stock Details
| Ticker Symbol | 7754 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0007754004 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Wenying Huang Ph.D. | Chair and Chief Executive Officer |
| Lewis Yeh | Chief Financial Officer |
| Junyan Ye | Accounting Supervisor |
| Dr. Dennis Huang M.D. | Head of Clinical Research and Medical Affairs |